On 6-7 June the kick off meeting of MTBVAC in Newborns took place in Cape Town, South Africa. This project contains a Phase 2a dose-defining safety and immunogenicity study is being carried out. [...]
EDCTP commits EUR 34M to TB vaccine clinical trials. True to the World Tuberculosis Day 2018 theme ‘Wanted: Leaders for a TB-free world’, the European Union and European member states continue to [...]
The initial results of the Phase 1b study have been presented at the 5th Global Forum on TB vaccines in Delhi. Please read the press release.
A new TB vaccine is an inevitability; the question is how long will it take us to get there? Please read the article about progress and challenges in TB vaccine development.
The Global Report on Tuberculosis Vaccines 2018 is prepared at the request of the Global TB Vaccine Partnership (GTBVP) leadership group. The report will be completed following the 5th Global [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
